Biocompatibility Essentials: Standards, Testing, and Risk Management

Interested participants from other time zones are welcome to contact us regarding the training at [email protected].

Biocompatibility is a fundamental requirement for all medical devices that come into contact with the human body. It ensures that materials and components do not cause harmful biological responses, such as toxicity, irritation, or sensitization, and that the device performs safely for its intended use. Regulatory authorities, including the EU under the Medical Device Regulation) and standards such as ISO 10993 emphasize rigorous biocompatibility assessment as part of the device development and risk management process.

This training provides participants with a comprehensive understanding of regulatory expectations, testing methodologies, and risk-based approaches to biocompatibility assessment. It bridges the gap between theoretical standards and practical implementation, enabling participants to ensure safety, compliance, and patient protection. 

Key Topics Covered

1.       Regulatory Framework and Standards

a.       Overview of MDR requirements related to biocompatibility.

b.      Introduction to ISO 10993 series and its application in device development.

c.       Integration of biocompatibility evaluation into the QMS and risk management.

2.       Biocompatibility Testing Strategies

a.       Identification of relevant endpoints (cytotoxicity, sensitization, irritation, systemic toxicity, genotoxicity, hemocompatibility, etc.)

b.      Selection of testing methods based on device type, material, and duration of contact.

c.       In vitro, in vivo, and chemical characterization approaches.

3.       Risk Assessment and Risk Management Integration

a.       Linking biocompatibility findings to overall device risk management (ISO 14971).

b.      Determining acceptability of risks and mitigation strategies.

c.       Use of literature, existing data, and equivalence justification to support biocompatibility claims.

4.       Documentation and Regulatory Submission

a.       Preparing comprehensive biocompatibility reports for regulatory review.

b.      Ensuring traceability of materials, test results, and risk assessments.

c.       Supporting technical documentation (Annex II) and clinical evaluation (Annex XIV).

5.       Best Practices and Lessons Learned

a.       Strategies for efficient testing and evaluation while ensuring compliance.

b.      Common pitfalls and audit findings related to biocompatibility.

c.       Case studies demonstrating successful biocompatibility programs. 

By the end of this session, participants will have the knowledge and tools to ensure that biocompatibility evaluation is performed systematically, documented thoroughly, and integrated effectively into risk management, ensuring both regulatory compliance and patient safety. 

Benefits of this Training

• Gain clarity on regulatory expectations and ISO standards for biocompatibility.
• Learn how to design and implement effective testing strategies for your devices.
• Understand how to integrate biocompatibility into risk management and clinical evaluation.
• Acquire practical guidance for documentation and audit readiness.
• Strengthen the ability to make informed, risk-based decisions regarding materials and device safety. 

Target Audience: Regulatory Affairs specialists and managers, Quality Assurance and Quality Managers, R&D Engineers, Clinical Affairs Managers. 

Certificate: Participants receive a Certificate of Attendance of DQS MED GmbH

Trainer: Is a highly qualified regulatory expert from DQS MED, a leading Notified Body with deep expertise in conformity assessment under EU MDR.